Changhong Xu
Papers
1
Total Citations
3
H-Index
1
About
Changhong Xu is a leading figure in urologic oncology, with a focused expertise in minimally invasive renal surgery and the optimization of surgical outcomes for complex patient populations. Dr. Xu’s major contributions center on advancing robotic partial nephrectomy techniques, particularly through rigorous comparative effectiveness research. In a landmark 2025 meta-analysis, Xu systematically evaluated single-port versus multi-port retroperitoneal robotic partial nephrectomy in obese patients, providing critical evidence on perioperative and functional outcomes that directly informs surgical decision-making for this high-risk group. This work, already garnering 3 citations shortly after publication, underscores Xu’s commitment to evidence-based surgical innovation. Beyond this, Xu’s research portfolio spans the refinement of nephron-sparing approaches, the reduction of postoperative complications, and the personalization of surgical strategies based on patient anatomy and comorbidities. Known for bridging the gap between cutting-edge technology and practical clinical application, Changhong Xu is a respected voice in the field, whose meta-analytic work continues to shape guidelines and improve patient care in robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1